Recap of the Boston Business Journal’s ‘Biotech in Boston’ event held on Thursday, August 4, 2022, at the Seaport Hotel. Kendalle Burlin O’Connell, President and COO of MassBio, was a panelist on the the real estate panel. Here is an excerpt:
Joining for the real estate panel were Kendalle Burlin O’Connell, the president and chief operating officer of MassBio; Bob Coughlin, managing director of JLL; and Tim Stoll, senior vice president of development and project management at Breakthrough Properties. Boston Business Journal executive editor Doug Banks moderated.
Coughlin and Burlin O’Connell both noted that while IPOs may be proceeding at a much slower rate than usual this year, Big Pharma and private venture capital firms are sitting on a lot of money. Consequently,…
Click here to view original post